Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Ropinirole Hydrochloride Sustained-release Tablets

Approval Number

国药准字H20244677

Company南京恒生制药有限公司

Registration Date

August 20, 2024

Drug Information

Generic Name

盐酸罗匹尼罗缓释片

Dosage Form

片剂

Strength

2mg（以C₁₆H₂₄N₂O计）

Drug Type

化学药品

Registration Date

August 20, 2024

Company Information

Applicant Company

Company Name南京恒生制药有限公司

Company Address

南京市溧水经济开发区机场路18 号

Manufacturing Company

Company Name南京恒生制药有限公司

Company Address

南京市溧水经济开发区机场路18 号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy